The dying stem cell hypothesis: Immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle

Journal of the American College of Cardiology

Volumn 46, Issue 10, 2005, Pages 1799-1802

  Thum, Thomas ^a,b   Bauersachs, Johann ^b   Poole Wilson, Philip A ^a   Volk, Hans Dieter ^c   Anker, Stefan D ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

ACUTE HEART INFARCTION; APOPTOSIS; ARTERY DISEASE; CELL ADHESION; CLINICAL TRIAL; DENDRITIC CELL; DONOR; DOWN REGULATION; HEART FAILURE; HEART FUNCTION; HUMAN; HYPERTENSION; HYPOTHESIS; IMMUNOMODULATION; IMMUNOREACTIVITY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MOLECULAR MECHANICS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REVIEW; SCAR FORMATION; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TISSUE REACTION; TREATMENT OUTCOME;

ANIMALS; CELL DEATH; HUMANS; IMMUNOTHERAPY; MYOCARDIUM; STEM CELL TRANSPLANTATION;

EID: 27644532831     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.07.053     Document Type: Review

References (27)

1. J.N. Cohn, M.R. Bristow, K.R. Chien Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research Circulation 95 1997 766 770
2. R. von Harsdorf, P.A. Poole-Wilson, R. Dietz Regenerative capacity of the myocardium implications for treatment of heart failure Lancet 363 2004 1306 1313
3. P. Anversa, B. Nadal-Ginard Myocyte renewal and ventricular remodelling Nature 415 2002 240 243
4. F.J. Neumann, I. Ott, M. Gawaz Cardiac release of cytokines and inflammatory responses in acute myocardial infarction Circulation 92 1995 748 755
5. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
6. N.G. Frangogiannis, C.W. Smith, M.L. Entman The inflammatory response in myocardial infarction Cardiovasc Res 53 2002 31 47
7. A. Saraste, K. Pulkki, M. Kallajoki, K. Henriksen, M. Parvinen, L.M. Voipio-Pulkki Apoptosis in human acute myocardial infarction Circulation 95 1997 320 323
8. G. Olivetti, F. Quaini, R. Sala Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart J Mol Cell Cardiol 28 1996 2005 2016
9. P.A. Krijnen, R. Nijmeijer, C.J. Meijer, C.A. Visser, C.E. Hack, H.W. Niessen Apoptosis in myocardial ischemia and infarction J Clin Pathol 55 2002 801 811
10. K.C. Wollert, G.P. Meyer, J. Lotz Intracoronary autologous bone-marrow cell transfer after myocardial infarction the BOOST randomised controlled clinical trial Lancet 364 2004 141 148
11. V. Schachinger, B. Assmus, M.B. Britten Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction final one-year results of the TOPCARE-AMI trial J Am Coll Cardiol 44 2004 1690 1699
12. C. Stamm, B. Westphal, H.D. Kleine Autologous bone-marrow stem-cell transplantation for myocardial regeneration Lancet 361 2003 45 46
13. Y.J. Geng Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure Ann N Y Acad Sci 1010 2003 687 697
14. R.E. Voll, M. Herrmann, E.A. Roth, C. Stach, J.R. Kalden, I. Girkontaite Immunosuppressive effects of apoptotic cells Nature 390 1997 350 351
15. S. Frantz, K.A. Vincent, O. Feron, R.A. Kelly Innate immunity and angiogenesis Circ Res 96 2005 15 26
16. S. Gallucci, M. Lolkema, P. Matzinger Natural adjuvants endogenous activators of dendritic cells Nat Med 5 1999 1249 1255
17. H. Jonuleit, E. Schmitt, G. Schuler, J. Knop, A.H. Enk Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells J Exp Med 192 2000 1213 1222
18. S. Read, F. Powrie CD4(+) regulatory T cells Curr Opin Immunol 13 2001 644 649
19. J.M. Austyn, D.F. Hankins, C.P. Larsen, P.J. Morris, A.S. Rao, J.A. Roake Isolation and characterization of dendritic cells from mouse heart and kidney J Immunol 152 1994 2401 2410
20. V.A. Fadok, D.L. Bratton, A. Konowal, P.W. Freed, J.Y. Westcott, P.M. Henson Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF J Clin Invest 101 1998 890 898
21. P. Maderna, C. Godson Phagocytosis of apoptotic cells and the resolution of inflammation Biochim Biophys Acta 1639 2003 141 151
22. S. Babaei, D.J. Stewart, P. Picard, J.C. Monge Effects of VasoCare therapy on the initiation and progression of atherosclerosis Atherosclerosis 162 2002 45 53
23. L.I. Edvinsson, M.L. Edvinsson, G. Angus Deveber Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease Int Angiol 22 2003 141 147
24. A.E. Bolton Biologic effects and basic science of a novel immune-modulation therapy Am J Cardiol 95 Suppl 2005 24C 29C
25. G. Torre-Amione, F. Sestier, B. Radovancevic, J. Young Effects of a novel immune modulation therapy in patients with advanced chronic heart failure results of a randomized, controlled, phase II trial J Am Coll Cardiol 44 2004 1181 1186
26. J. Tremblay, H. Chen, J. Peng Renal ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapy Transplantation 74 2002 1425 1433
27. M.L. Huynh, V.A. Fadok, P.M. Henson Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation J Clin Invest 109 2002 41 50